Menu

Question 1301

Topic: Biology, Genetics & Bone Healing

Osteoclasts are specialized, multinucleated bone-resorbing cells. They are directly derived from which of the following cellular lineages?

. Mesenchymal stem cells
. Neural crest cells
. Endodermal progenitors
. Monocyte/macrophage hematopoietic lineage
. Fibroblastic lineage

Correct Answer & Explanation

. Mesenchymal stem cells


Explanation

Osteoclasts are derived from the monocyte/macrophage hematopoietic stem cell lineage. Their differentiation and multinucleation are primarily driven by Macrophage Colony-Stimulating Factor (M-CSF) and RANKL.

Question 1302

Topic: Biology, Genetics & Bone Healing

Teriparatide is utilized for the treatment of severe osteoporosis to decrease fracture risk. What is its fundamental mechanism of action when administered via daily subcutaneous injections?

. Continuous activation of PTH receptors leading to bone resorption
. Intermittent activation of PTH receptors stimulating osteoblast activity
. Inhibition of sclerostin leading to increased bone formation
. Direct inhibition of osteoclast ruffled border formation
. Upregulation of OPG production by T-cells

Correct Answer & Explanation

. Continuous activation of PTH receptors leading to bone resorption


Explanation

Teriparatide is a recombinant human parathyroid hormone fragment (PTH 1-34). While continuous PTH elevation causes net bone resorption, intermittent administration (such as daily injections) preferentially stimulates osteoblast activity, resulting in net bone formation.

Question 1303

Topic: Biology, Genetics & Bone Healing

During the incorporation of a massive cortical structural allograft, the process of "creeping substitution" occurs. This process is best characterized by:

. Simultaneous rapid resorption of the entire graft followed by replacement with woven bone
. Osteoclastic cutting cones advancing through the graft followed immediately by osteoblasts laying down new bone
. Complete retention and survival of donor osteocytes
. Rejection of the graft by the host's cellular immune system
. Immediate revascularization of the Haversian canals without any prior resorption

Correct Answer & Explanation

. Simultaneous rapid resorption of the entire graft followed by replacement with woven bone


Explanation

Creeping substitution in cortical bone grafts involves the invasion of osteoclastic cutting cones that resorb the dead allograft bone, followed closely by osteoblasts laying down viable host bone. This process temporarily weakens the graft mechanically before full incorporation.

Question 1304

Topic: Biology, Genetics & Bone Healing

A 45-year-old woman presents with diffuse skeletal pain and proximal muscle weakness. Laboratory studies reveal normal serum calcium, decreased phosphate, elevated alkaline phosphatase, and severely low 25-hydroxyvitamin D. A bone biopsy would most likely show:

. Increased woven bone with prominent irregular cement lines
. Thinning of trabeculae with structurally normal mineralization
. Accumulation of thick, unmineralized osteoid seams
. Complete absence of functioning osteoclasts
. Replacement of the marrow space with highly vascularized fibrous tissue

Correct Answer & Explanation

. Increased woven bone with prominent irregular cement lines


Explanation

The patient's clinical and laboratory findings are highly consistent with osteomalacia due to severe Vitamin D deficiency. Histologically, osteomalacia is defined by a profound defect in bone mineralization, leading to the accumulation of unmineralized osteoid.

Question 1305

Topic: Biology, Genetics & Bone Healing

Romosozumab is a newer monoclonal antibody utilized for osteoporosis treatment that functions by inhibiting sclerostin. What is the normal physiological function of sclerostin in bone metabolism?

. It binds to RANKL to inhibit osteoclastogenesis
. It promotes the differentiation of hematopoietic stem cells into macrophages
. It inhibits the Wnt/beta-catenin signaling pathway to decrease osteoblast activity
. It cleaves procollagen to form mature Type I collagen fibers
. It stimulates the conversion of 25-hydroxyvitamin D to its active form

Correct Answer & Explanation

. It binds to RANKL to inhibit osteoclastogenesis


Explanation

Sclerostin is a glycoprotein secreted primarily by mature osteocytes that negatively regulates bone formation. It functions by binding to LRP5/6 receptors on osteoblasts, which directly inhibits the osteogenic Wnt/beta-catenin signaling pathway.

Question 1306

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman with severe osteoporosis is started on romosozumab. This medication increases bone mass primarily by inhibiting which of the following targets?

. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Sclerostin
. Cathepsin K
. Farnesyl pyrophosphate synthase
. Parathyroid hormone (PTH) receptor

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

Romosozumab is a monoclonal antibody that binds and inhibits sclerostin. Sclerostin normally inhibits the Wnt/beta-catenin signaling pathway, so its inhibition leads to increased osteoblastic bone formation.

Question 1307

Topic: Biology, Genetics & Bone Healing

Which of the following best describes the molecular mechanism of action of nitrogen-containing bisphosphonates (e.g., alendronate) in the treatment of osteoporosis?

. Inhibition of Cathepsin K at the ruffled border
. Competitive binding of the RANK receptor on osteoclasts
. Inhibition of farnesyl pyrophosphate synthase in the mevalonate pathway
. Direct stimulation of osteoprotegerin (OPG) secretion
. Downregulation of Wnt/beta-catenin signaling

Correct Answer & Explanation

. Inhibition of Cathepsin K at the ruffled border


Explanation

Nitrogen-containing bisphosphonates inhibit farnesyl pyrophosphate synthase in the mevalonate pathway. This prevents prenylation of small GTPases essential for osteoclast function, leading to osteoclast apoptosis.

Question 1308

Topic: Biology, Genetics & Bone Healing

Distraction osteogenesis is utilized in limb lengthening procedures using circular frames. Assuming stable fixation and an appropriate distraction rate, the new regenerate bone forms primarily via which mechanism?

. Endochondral ossification
. Intramembranous ossification
. Appositional bone growth
. Chondroclast resorption
. Creeping substitution

Correct Answer & Explanation

. Endochondral ossification


Explanation

Under conditions of mechanical stability and steady tension, bone regenerates primarily via intramembranous ossification without a cartilaginous intermediate. If the construct is mechanically unstable, endochondral ossification or nonunion may occur.

Question 1309

Topic: Biology, Genetics & Bone Healing

Denosumab is highly effective at reducing fracture risk in severe osteoporosis. Which of the following naturally occurring molecules does denosumab functionally mimic?

. RANKL
. Osteoprotegerin (OPG)
. Osteopontin
. Calcitonin
. Bone morphogenetic protein-2 (BMP-2)

Correct Answer & Explanation

. RANKL


Explanation

Denosumab is a monoclonal antibody that binds to RANKL, preventing it from interacting with the RANK receptor on osteoclasts. This mechanism effectively mimics the natural decoy receptor Osteoprotegerin (OPG).

Question 1310

Topic: Biology, Genetics & Bone Healing

Recombinant human bone morphogenetic proteins (e.g., rhBMP-2) are frequently used to enhance spinal fusion. BMPs exert their intracellular osteogenic effects primarily through which signaling pathway?

. Wnt/beta-catenin
. Smad 1/5/8
. MAPK/ERK
. JAK/STAT
. Notch signaling

Correct Answer & Explanation

. Wnt/beta-catenin


Explanation

BMPs bind to serine/threonine kinase receptors on the cell surface, leading to the phosphorylation and activation of receptor-regulated Smads (Smad 1, 5, and 8). These translocate to the nucleus to induce osteogenic gene transcription.

Question 1311

Topic: Biology, Genetics & Bone Healing

A 12-year-old child presents with a congenital bone disorder characterized by dense, brittle bones and the absence of medullary canals. A mutation in the CLCN7 gene is identified. This mutation primarily impairs which specific process?

. Osteoblast collagen type I synthesis
. Osteoclast ruffled border hydrogen ion secretion
. Osteoclast chloride channel function
. Osteocyte canalicular mechanotransduction
. Chondrocyte hypertrophy in the physis

Correct Answer & Explanation

. Osteoblast collagen type I synthesis


Explanation

The patient has osteopetrosis, caused by defects in osteoclast acidification of the resorption pit. The CLCN7 gene encodes a chloride channel necessary to maintain electroneutrality when the V-ATPase pumps hydrogen ions into the resorption lacuna.

Question 1312

Topic: Biology, Genetics & Bone Healing

Continuous (chronic) elevation of parathyroid hormone (PTH) leads to increased bone resorption. Which cell type contains the primary PTH receptor responsible for initiating this specific resorptive cascade?

. Osteoclasts
. Osteoblasts
. Macrophages
. Chondrocytes
. Mesenchymal stem cells

Correct Answer & Explanation

. Osteoclasts


Explanation

Mature osteoclasts lack PTH receptors. Chronic PTH elevation directly stimulates osteoblasts (and osteocytes) via the PTH1R receptor to upregulate RANKL expression, which subsequently activates osteoclasts to resorb bone.

Question 1313

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman is treated for postmenopausal osteoporosis with a monoclonal antibody that mimics the action of osteoprotegerin (OPG). What is the direct molecular target of this medication?

. RANK receptor
. RANK ligand (RANKL)
. Cathepsin K
. Farnesyl pyrophosphate synthase
. Sclerostin

Correct Answer & Explanation

. RANK receptor


Explanation

Denosumab is a monoclonal antibody that binds directly to RANKL, mimicking the physiologic role of OPG. This prevents RANKL from binding to the RANK receptor on osteoclasts, thereby inhibiting osteoclast activation and bone resorption.

Question 1314

Topic: Biology, Genetics & Bone Healing

A 72-year-old man receives alendronate for the treatment of osteoporosis. At the cellular level, this medication inhibits bone resorption primarily through the direct inhibition of which of the following enzymes?

. Cathepsin K
. Tartrate-resistant acid phosphatase
. Carbonic anhydrase II
. Farnesyl pyrophosphate synthase
. Matrix metalloproteinase-9

Correct Answer & Explanation

. Cathepsin K


Explanation

Nitrogen-containing bisphosphonates, such as alendronate, inhibit farnesyl pyrophosphate synthase within the mevalonate pathway. This disruption impairs osteoclast function and promotes osteoclast apoptosis, preventing bone resorption.

Question 1315

Topic: Biology, Genetics & Bone Healing

A newer pharmacological agent for the treatment of severe osteoporosis acts by inhibiting sclerostin. What is the primary downstream effect of this medication on bone metabolism?

. Inhibition of the RANKL pathway
. Stimulation of the Wnt/beta-catenin signaling pathway
. Direct activation of calcium-sensing receptors
. Inhibition of farnesyl pyrophosphate synthase
. Activation of osteoclast apoptosis

Correct Answer & Explanation

. Inhibition of the RANKL pathway


Explanation

Sclerostin, normally secreted by osteocytes, acts as a negative regulator of bone formation by inhibiting the Wnt/beta-catenin pathway. Monoclonal antibodies against sclerostin (e.g., romosozumab) block this inhibition, stimulating the Wnt pathway and driving osteoblastic bone formation.

Question 1316

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a critical role in osteoinduction. Following binding to their cell surface receptors, BMPs primarily transduce their intracellular signals via which of the following pathways?

. JAK/STAT pathway
. cAMP/PKA pathway
. Smad 1/5/8 pathway
. Wnt/beta-catenin pathway
. MAP kinase pathway

Correct Answer & Explanation

. JAK/STAT pathway


Explanation

BMP signaling is primarily mediated through the phosphorylation of intracellular Smad proteins, specifically Smads 1, 5, and 8. These phosphorylated proteins form a complex with Smad 4, which then translocates to the nucleus to initiate osteogenic gene transcription.

Question 1317

Topic: Biology, Genetics & Bone Healing

Intermittent administration of recombinant human parathyroid hormone (PTH 1-34) is utilized in the treatment of osteoporosis. What is the primary mechanism by which intermittent dosing increases bone mass?

. Directly inhibiting osteoclast action
. Upregulating sclerostin production by osteocytes
. Stimulating osteoblastic bone formation more than bone resorption
. Enhancing renal calcium excretion
. Inhibiting the RANKL/RANK interaction

Correct Answer & Explanation

. Directly inhibiting osteoclast action


Explanation

While continuous endogenous PTH exposure leads to net bone resorption, intermittent pharmacological administration (like daily teriparatide injections) preferentially stimulates osteoblast activity over osteoclasts. This creates an anabolic window that leads to increased bone mineral density.

Question 1318

Topic: Biology, Genetics & Bone Healing

A 4-year-old child presents with bowing of the legs, hypocalcemia, hypophosphatemia, and markedly elevated alkaline phosphatase. A defect in which of the following enzymes is responsible for Vitamin D-dependent rickets type I?

. 25-hydroxylase
. 1-alpha-hydroxylase
. 24-hydroxylase
. Alkaline phosphatase
. PHEX

Correct Answer & Explanation

. 25-hydroxylase


Explanation

Vitamin D-dependent rickets type I is an autosomal recessive disorder caused by a mutation in the 1-alpha-hydroxylase enzyme in the kidney. This prevents the conversion of 25-hydroxyvitamin D into its active form, 1,25-dihydroxyvitamin D, leading to defective bone mineralization.

Question 1319

Topic: Biology, Genetics & Bone Healing

A 4-year-old boy with blue sclerae and a history of four extremity fractures after minimal trauma is diagnosed with severe Osteogenesis Imperfecta (OI). Which of the following pharmacological therapies is currently the standard of care to decrease fracture incidence and increase bone mineral density in this patient?

. Intravenous pamidronate
. Oral calcium and cholecalciferol supplementation
. Recombinant human growth hormone
. Teriparatide
. Intranasal calcitonin

Correct Answer & Explanation

. Intravenous pamidronate


Explanation

Intravenous bisphosphonates (such as pamidronate or zoledronic acid) are the standard of care for children with moderate to severe Osteogenesis Imperfecta. They inhibit osteoclast-mediated bone resorption, which leads to increased bone mineral density, decreased bone pain, and a significant reduction in the incidence of fractures.

Question 1320

Topic: Biology, Genetics & Bone Healing
A 4-year-old child with a history of recurrent fractures, blue sclerae, and dentinogenesis imperfecta is diagnosed with osteogenesis imperfecta (OI) type III. In order to decrease the fracture burden and correct progressive long-bone deformities, what is the current gold standard combined medical and surgical management strategy?
. Calcium channel blockers and rigid solid intramedullary nailing
. Intravenous bisphosphonates and telescopic intramedullary rodding
. Oral corticosteroids and plate fixation
. Vitamin D supplementation and external fixation
. Growth hormone therapy and soft-tissue release

Correct Answer & Explanation

. Intravenous bisphosphonates and telescopic intramedullary rodding


Explanation

The medical management of severe osteogenesis imperfecta heavily relies on bisphosphonates (often administered intravenously, like pamidronate), which inhibit osteoclast resorption and increase bone density, significantly reducing fracture rates. Surgically, the use of telescopic (growing) intramedullary rods, such as the Fassier-Duval rod, is the gold standard for long-bone deformities in growing children with OI. Telescopic rods accommodate growth, providing internal splinting that decreases the likelihood of recurrent fractures and rod migration compared to static solid nails or plates.